Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

A company that has Donald Trump Jr. on its board debuted a new service to help pharmaceutical companies launch direct sales ...

Six months into Donald Trump’s second term, his administration is at war with the federal judiciary, evading court orders ...

The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be retreating from them.

Eli Lilly and Co. has already launched LillyDirect service, which CEO David Ricks says jibes with the administration’s demand ...

Robert F. Kennedy Jr. has announced that his department will end funding for a series of mRNA-based vaccines aimed at ...

Pfizer ( PFE) shares gained on Tuesday after the New York-based pharma giant reported better-than-expected financials for Q2 2025 and increased its full-year earnings outlook, citing, among other ...

An official overseeing implementation of the Make America Healthy Again agenda at the Department of Health and Human Services ...

CSL Seqirus was one of the drugmakers the federal government listed this week as having its mRNA-related work cut. In an ...

SERB Pharmaceuticals plans to buy Y-mAbs Pharmaceuticals in a $412 million all-cash deal. CorMedix bought Melinta ...

In justifying the government's termination of $500 million in funding for mRNA vaccine projects, Health and Human Services ...